Fundz

Fina Biosolutions reported raising $3 Million in an initial SEC Form D filing, from an offering of $3 Million

PRIVATENov 14, 2024

Amount Raised

$3 Million

$3 Million sold, per SEC Form D (first sale Nov 8, 2024)

Round Type

Seed

RockvilleBiotechnology

Quick answer

Fina BioSolutions raised $3 Million in a Seed round, dated November 8, 2024. Fina BioSolutions is based in Rockville, Maryland, United States.

How much did Fina BioSolutions raise?
Fina BioSolutions raised $3 Million in a Seed round on November 8, 2024.
What does Fina BioSolutions do?
Fina Biosolutions LLC is a privately held research and development stage biotechnology company that discovers, develops, and collaborates to commercialize novel vaccine conjugates for prevention of life-threatening..
Where is Fina BioSolutions based and how big is it?
Fina BioSolutions is based in Rockville, Maryland, United States. Fundz records about 8 employees.
Who are the decision-makers at Fina BioSolutions?
Fundz holds 1 contact at Fina BioSolutions. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Fina BioSolutions that raised within 45 days of this round, from Fundz verified event records.

  • Lipella Pharmaceuticals raised $2.6M (Seed) on December 23, 2024.
  • Marker Therapeutics raised $16M on December 23, 2024.
  • Orcosa raised $7.3M on December 23, 2024.
  • Telo Genomics raised $10K (Pre-Seed) on December 23, 2024.
  • GEMMABio raised $34M (Series A) on December 23, 2024.
  • Level Zero Health raised $7M on December 23, 2024.

Who to call at Fina BioSolutions, and when

A new round usually means Fina BioSolutions is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Fina BioSolutions raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Fina BioSolutions, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Fina BioSolutions. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Fina BioSolutions

Location

Rockville, Maryland, United States

About

Fina Biosolutions LLC is a privately held research and development stage biotechnology company that discovers, develops, and collaborates to commercialize novel vaccine conjugates for prevention of life-threatening diseases. Fina has patented novel techniques to conjugate, purify, and manufacture conjugates using its proprietary chemistry to create complex conjugate vaccines. The technology is currently licensed by leading vaccine manufacturers in both Europe and Asia, including GlaxoSmithKline for marketed vaccines Synflorix™ Menitorix™, Nimenrix™, The Serum Institute of India Ltd., The Chengdu Institute of Biological Products and others. Fina Biosolutions also manufactures E. coli expressed CRM197 conjugate vaccine carrier protein. Fina BioSolutions also develops polymer based diagnostic reagents, amino dextran, and antibody dextran conjugates.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Fina BioSolutions raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Fina BioSolutions's next move

See what Strategic adds

Fina BioSolutions raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.